“HK Startups Meet Multinational Companies Series” is an ongoing series of meetings, showcasing Inspiration, connecting start-ups with corporates, and building a successful, sustainable innovation community in Hong Kong.
COVID-19 brought Biotech and Healthtech to the forefront of public attention, policy, and investment, as the race for treatments and cures to enable long-term re-opening of economies accelerated. Hong Kong has actually played a leading global role in critical COVID research – and Biotech/Healthtech research and advancements for other diseases and health issues. And Biotech features prominently in Hong Kong startup activity, emphasis and support. What Biotech/Healthtech sectors will see winning startups emerge in Hong Kong? What is Hong Kong’s long-term role in the global Biotech/Healthtech innovation ecosystem?
Join us on September 25 for the fifth session: Vigor. We will invite start-ups with technologies that contribute to Biotech/Healthtech innovations for corporates, government, and society.